Skip to Main Content

FDA Looks To Quickly Review Treatments, Tests For COVID-19, Commissioner Says

  • June 11, 2020

Reuters (6/10, Beasley) reports the FDA “is seeking to review treatments and tests for COVID-19 ‘as fast as we can’ for emergency clearance, with the priority on those using high-level science, the agency’s commissioner said on Wednesday.” The agency “aims to expedite products with the greatest chance of making it through the clinical trial process and eventually helping people, FDA Commissioner Stephen Hahn said during a conference held by the Biotechnology Innovation Organization.”